Your Comments On...

Divided Loyalties?

Diabetes patients anxious to weigh the pros and cons of an experimental diabetes drug called muraglitazar might expect some help from the American Diabetes Association (ADA). But they won't find much on the ADA Web site. Industry funding of medical research has been on the rise since Congress......
 - 

By Tinker Ready

 
Comments
© 2006 The Washington Post Company